Invention Grant
US08410139B2 Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity
有权
哌啶衍生物的前药作为趋化因子受体活性的调节剂
- Patent Title: Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity
- Patent Title (中): 哌啶衍生物的前药作为趋化因子受体活性的调节剂
-
Application No.: US12896955Application Date: 2010-10-04
-
Publication No.: US08410139B2Publication Date: 2013-04-02
- Inventor: John Hynes , Percy H. Carter , Lyndon A. M. Cornelius , T.G. Murali Dhar , John V. Duncia , Satheesh Nair , Joseph B. Santella , Jayakumar S. Warrier , Hong Wu
- Applicant: John Hynes , Percy H. Carter , Lyndon A. M. Cornelius , T.G. Murali Dhar , John V. Duncia , Satheesh Nair , Joseph B. Santella , Jayakumar S. Warrier , Hong Wu
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Laurelee A. Duncan; Elliott Korsen; Hong Liu
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D211/44
Abstract:
The present application describes prodrugs of the compound of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis using the prodrug compounds of the invention are disclosed.
Public/Granted literature
- US20110082113A1 PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Public/Granted day:2011-04-07
Information query
IPC分类:
